Why is Medicamen Organ. falling/rising?

As of 01-Aug, Medicamen Organics Ltd is experiencing a significant decline in its stock price, currently at 0.00, reflecting a change of -44.75, which is a decrease of 100.0%. The stock has seen a drastic drop in investor participation, with a delivery volume of 2,000 shares on July 31, which is a staggering 92.96% lower than the 5-day average delivery volume. Additionally, the stock's liquidity is limited, as it is based on only 2% of the 5-day average traded value, indicating that it is not liquid enough for substantial trading activity. There are no available positive or negative factors to provide further context on the stock's recent movement.
In terms of broader market context, there is no data available for stock versus benchmark returns, which limits the ability to compare Medicamen Organics Ltd's performance against market trends. The lack of investor interest and the significant drop in trading volume suggest a negative sentiment surrounding the stock, which may be contributing to its current price decline. Without additional market data, it is challenging to assess how external factors may be influencing the stock's performance relative to its peers.